echoloc

Prothya Biosolutions Tech Stack

Plasma fractionation and protein therapy manufacturing at scale

Pharmaceutical Manufacturing Neder-Over-Heembeek, Brussels 1,001–5,000 employees Founded 2021 Privately Held

Prothya Biosolutions operates a plasma-to-therapeutics manufacturing footprint processing ~3 million liters annually. The tech stack is operationally mature—heavy on Siemens automation (Step 7, TIA Portal), SAP (including SuccessFactors and modules for warehouse/PM), and analytical instrumentation (HPLC, SDS-PAGE)—but shows no adopting or replacing signals, suggesting stable, compliance-locked infrastructure. Hiring velocity is accelerating across manufacturing and quality (16 of 35 active roles), with notable Clinical Development and Quality Director searches, indicating scale-up in both production throughput and regulatory capability.

Tech Stack 29 technologies

Core StackSAP Power BI Siemens SAP SuccessFactors Siemens Step 7 TIA Portal Wonderware Ignition PLCs SCADA HMIs ABB Rockwell Automation Structured Text Modbus Ethernet/IP PROFIBUS AFAS HPLC SDS-PAGE Minitab GCP CMMS SAP PM DCS HMI SAP WM MES Microsoft Access

What Prothya Biosolutions Is Building

Challenges

  • Ensuring gmp compliance
  • Optimizing ra processes
  • Ensuring raw material availability
  • Reducing production deviations
  • Ensuring production continuity
  • Reducing recurring issues
  • Non-conformance investigation
  • Maintaining long-term production planning
  • Data quality in supply chain
  • Master data change management

Active Projects

  • It/ot automation projects
  • Design and maintain qse training plans
  • Deviation management
  • Month-end and year-end closing process
  • Annual audit process
  • Inventory analysis and reconciliation
  • Annual shutdown planning
  • Preventive maintenance scheduling
  • Plc and scada system upgrades
  • Capa execution & follow-up

Hiring Activity

Accelerating35 roles · 30 in 30d

Department

Manufacturing
8
Quality
8
Engineering
7
HR
3
Ops
3
Data
1
Finance
1
Healthcare
1

Seniority

Senior
15
Mid
11
Director
2
Junior
2
Lead
2
Manager
2
Intern
1

Notable leadership hires: Clinical Development Lead, Quality Director

Company intelligence

Find more companies like Prothya Biosolutions by tech stack, pain points and active projects

Get started free

About Prothya Biosolutions

Prothya Biosolutions manufactures plasma-derived medicinal products and protein therapeutics, formed in 2021 from the merger of Plasma Industries Belgium (with roots in the Belgian Red Cross) and Sanquin Plasma Products. The company processes approximately 3 million liters of plasma annually and produces stable plasma derivatives including clotting factors, immunoglobulins, and albumin solutions. Headquartered in Brussels, the company operates as a contract manufacturer and development partner for international pharmaceutical firms. With 1,001–5,000 employees across manufacturing, quality, engineering, and clinical functions, Prothya is expanding global presence through active hiring in Belgium, Netherlands, Canada, Peru, and the United States.

HeadquartersNeder-Over-Heembeek, Brussels
Company Size1,001–5,000 employees
Founded2021
Hiring MarketsNetherlands, Belgium, Canada, Peru, United States

Frequently Asked Questions

What is Prothya Biosolutions' main product?

Prothya manufactures plasma-derived medicinal products including clotting factors, immunoglobulins, and albumin solutions, processed from ~3 million liters of plasma annually for international pharmaceutical partners.

Where is Prothya Biosolutions headquartered?

Prothya is headquartered in Neder-Over-Heembeek, Brussels, Belgium, and currently hiring across Belgium, Netherlands, Canada, Peru, and the United States.

How this profile is built

Prothya Biosolutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.